Yes, a bacteriophage is a virus. Specifically, it’s a virus that infects bacteria rather than animals, plants, or humans. The name itself reflects this: “bacteriophage” comes from Greek words meaning “bacteria eater.” Scientists often shorten it to just “phage.” In formal taxonomy, phages are classified by the International Committee on the Taxonomy of Viruses (ICTV), organized into 22 families under the Bacterial and Archaeal Viruses Subcommittee.
What Makes a Phage a Virus
Bacteriophages share the defining traits of all viruses. They can’t reproduce on their own. They have no metabolism, no ribosomes, no way to generate energy. Instead, they hijack a living cell’s machinery to copy themselves. This makes them obligate intracellular pathogens, the same fundamental category that includes influenza, HIV, and every other virus you’ve heard of.
Like other viruses, phages consist of genetic material wrapped in a protein shell called a capsid. The well-studied phage T4, for example, carries 172 kilobases of double-stranded DNA inside an elongated capsid built from a lattice of proteins. Some phages use RNA instead of DNA, just as some human viruses do. The key distinction isn’t in what phages are, but in what they target.
How Phages Differ From Human Viruses
The most important difference between a bacteriophage and a virus like the flu is the host. Phages infect only bacteria (and sometimes archaea). They do this by recognizing specific molecules on the bacterial surface using specialized “receptor binding proteins” located at the tips of their tail fibers. These proteins lock onto structures unique to bacteria, such as lipopolysaccharides, peptidoglycan, teichoic acids, or surface proteins. Human cells don’t have these structures, so phages can’t infect them in the way they infect bacteria.
This specificity is remarkably narrow. A phage that infects one species of bacteria often can’t infect a closely related species, because the surface receptors differ. This is a core reason phages are considered safe for medical use in humans.
Structurally, many phages also look quite different from the viruses that infect us. The classic tailed phage has a head, a rigid or contractile tail, and spindly tail fibers radiating from a baseplate. It looks something like a lunar lander. Human viruses tend to be simpler spheres or enveloped particles. A typical tailed phage measures about 100 nanometers across, roughly one-tenth the diameter of the bacteria it infects.
How Phages Infect Bacteria
Phages reproduce through two main cycles. In the lytic cycle, the phage attaches to a bacterium, injects its genetic material, and commandeers the cell’s protein-making machinery. The bacterium rapidly churns out new copies of the phage’s DNA and assembles new capsids. When enough new phages have been built, the bacterial cell bursts open (lyses) and releases them to infect more bacteria. The host cell is destroyed in the process.
In the lysogenic cycle, the phage takes a subtler approach. It still attaches and injects its DNA, but instead of immediately replicating, the phage genome integrates into the bacterium’s own chromosome. In this dormant form, called a prophage, it gets copied every time the bacterium divides. The bacterium survives and passes the phage DNA to its daughter cells. This can continue for many generations until an environmental trigger, like UV light or nutrient stress, flips the switch back to lytic mode, killing the host.
The Most Abundant Organisms on Earth
Phages are everywhere bacteria are, and since bacteria are everywhere, that means phages are staggeringly common. Current estimates put the total number of phage particles on Earth at around 10 to the power of 31. To put that in perspective, that works out to roughly a trillion phages for every grain of sand on the planet. They’re found in soil, oceans, hot springs, the human gut, sewage, and essentially every ecosystem that supports bacterial life.
This abundance matters ecologically. Phages are major drivers of bacterial evolution and population control. By killing bacteria, they recycle nutrients back into ecosystems. By transferring DNA between hosts during lysogeny, they shuffle genes across bacterial populations, sometimes spreading traits like toxin production or antibiotic resistance.
Phage Therapy for Antibiotic-Resistant Infections
Because phages kill bacteria with high specificity, researchers have long explored using them as treatments for bacterial infections. This idea, called phage therapy, dates back to the early 20th century, when Frederick Twort and Félix d’Hérelle independently discovered bacteriophages in 1915 and 1917. The approach fell out of favor in Western medicine after antibiotics became widely available, but it never disappeared entirely. Countries in Eastern Europe, particularly Georgia, have used phage therapy for decades.
Now, with antibiotic resistance becoming a global crisis, phage therapy is attracting renewed interest. The World Health Organization identifies it as a promising tool for controlling antimicrobial resistance. Case studies have shown success against notoriously difficult infections caused by MRSA and drug-resistant Pseudomonas. Approximately 90 clinical trials involving bacteriophages are ongoing worldwide, with 41 of them in the United States. In the U.S., the FDA classifies therapeutic phage products as biological products, regulated similarly to vaccines and cell therapies.
For now, phage therapy is primarily used on compassionate grounds in Western countries, reserved for life-threatening infections when all other treatments have failed. Phages can also be paired with antibiotics to boost their effectiveness. On the food safety side, the FDA has already approved phage-based products to control bacterial contamination in food processing, with approvals dating back to 2006.
Can Phages Affect Human Cells?
Phages don’t infect human cells the way they infect bacteria. They can’t hijack our cellular machinery or replicate inside us. However, research has shown that phages aren’t completely inert in the human body. Studies using human epithelial cells from the gut, lungs, liver, brain, and kidneys found that phage particles can cross cell layers through a process called transcytosis. In this process, a cell engulfs the phage in a small vesicle, shuttles it through the cell’s internal transport system, and releases it on the other side. This allows phages to move through tissue barriers like the gut lining and potentially enter the bloodstream.
This doesn’t mean phages are harmful to human cells. They pass through without replicating or damaging the cell. But it does mean they interact with our bodies in ways scientists are still working to fully understand, which is one reason regulatory approval for phage therapies has moved cautiously.